Nasdaq

EDWARDS PASCAL PRECISION TRANSCATHETER MITRAL AND TRICUSPID VALVE REPAIR SYSTEM RECEIVES CE MARK

IRVINE, Calif., Aug. 17, 2022 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), today announced the company's PASCAL Precision transcatheter valve repair system received CE Mark for the ...
Nasdaq

EDWARDS PASCAL PRECISION TRANSCATHETER VALVE REPAIR SYSTEM RECEIVES FDA APPROVAL FOR DEGENERATIVE MITRAL REGURGITATION

IRVINE, Calif., Sept. 15, 2022 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), today announced the company's PASCAL Precision transcatheter valve repair system for transcatheter ...
EurekAlert!

Novel TEER repair device meets primary endpoint in treating degenerative mitral regurgitation in patients not eligible for surgery

BOSTON – September 17, 2022 – Results of the first randomized controlled trial to directly compare two contemporary transcatheter edge-to-edge repair (TEER) devices for degenerative mitral ...
TCTMD

Pascal Transcatheter Device Safe, Improves Tricuspid Regurgitation: Early Results

CHICAGO, IL—In experienced hands, compassionate use of the Pascal transcatheter valve repair system in patients with severe high-risk or inoperable tricuspid regurgitation (TR) can be safe and ...
Medscape

PASCAL Mitral Valve Repair Shines at 2 Years in CLASP

Transcatheter mitral valve repair with the PASCAL device showed high rates of survival and freedom from heart failure rehospitalization at 2 years in the single-arm, safety and efficacy CLASP study.
Hosted on MSN

Edwards Lifesciences’ PASCAL System: A Promising Trial in Heart Valve Repair

Edwards Lifesciences Corp. ((EW)) announced an update on their ongoing clinical study. Edwards Lifesciences Corp. is currently conducting a pivotal clinical trial titled ‘Edwards PASCAL Transcatheter ...
MD&M East

Edwards Makes Gains in Tricuspid Regurgitation Repair with CE Mark

The Irvine, CA-based company said the Pascal repair system demonstrated high procedural success and significant clinical improvements in patients with challenging tricuspid anatomy and severe TR.
BioWorld

Edwards receives CE mark for Pascal tricuspid repair to compete with Abbott’s Triclip

Edwards Lifesciences Corp. has gained a CE mark for its Pascal transcatheter valve repair system to treat tricuspid regurgitation (TR). It was previously approved for mitral regurgitation treatment.
Yahoo Finance

Edwards gets Q1 boost as Pascal valve repair sales ramp up

Edwards Lifesciences said expanded use of its Pascal transcatheter valve repair system drove strong sales in the first quarter as an increasing number of heart centers adopt the technology. Meanwhile, ...
Baylor College of Medicine

Clasp II TR: Trial to evaluate transcatheter tricuspid valve repair with the Edwards Pascal Transcatheter valve repair system

Study coordinators who want to add a study should Submit a Clinical Trial. For more information or to remove a study, please email pa-webteam@bcm.edu. MyChart is a ...
TCTMD

TCT ID 2: The PASCAL Transcatheter Valve Repair System for the Treatment of Tricuspid Regurgitation – Day Outcomes From the CLASP TR Early Feasibility Study

TCT 059: Meta-Analysis of Bleeding, MACE and Mortality in Clinical Trials of Time-Constrained Dual-Antiplatelet Therapy After PCI Receive the the latest news, research, and presentations from major ...